The following question and answer appeared in an article by Daniela Held in the June 2008 issue of The Column, LCGC Europe’s e-zine. Why does GPC–SEC require a calibration?
The following question and answer appeared in an article by Daniela Held in the June 2008 issue of The Column, LCGC Europe’s e-zine.
Why does GPCâSEC require a calibration?
The primary information obtained from gel permeation chromatography (GPC)âsize-exclusion chromatography (SEC) standard detectors (for example, UV, evaporative light scattering, or refractive index) is not the molar mass but the apparent concentration at a certain elution volume. It is only with the GPCâSEC calibration curve and the concentration profile from the concentration detector that all molar mass averages and the molar mass distribution can be obtained (1,2). GPCâSEC is, therefore, a relative method. The GPCâSEC calibration is based on assigning the elution volume to a molar mass. This is in contrast to high performance liquid chromatography (HPLC), where the detector response (signal intensity, peak area) is calibrated and assigned to a concentration.
Another possibility to measure the relation of the molar mass to elution volume is to apply an on-line light scattering detector (low-angle, right-angle, and multiangle laser light scattering but not evaporative light scattering) and a concentration detector (UV, refractive index, evaporative light scattering). With such a combination a calibration curve valid for a specific sample is measured with the sample itself. To obtain smooth molar mass distributions, light-scattering software programs often provide the use of fitted data, where (same as in conventional calibration curves) the molar mass/elution volume relation is fitted. Proper data analysis also requires the detector constant (calibration constant) of the light-scattering detector and of the concentration factor (response factor). For the concentration detector, the constant is comparable to detector calibrations performed in HPLC and obtained in a similar way.
(1) D. Held, The Column, 8 (August 2007).
(2) D. Held and G. Reinhold, The Column, 10 (October 2007).
Questions?
LCGC technical editor Steve Brown will answer your technical questions. Each month, one question will be selected to appear in this space, so we welcome your submissions. Please send all questions to the attention of "Ask the Editor" at lcgcedit@lcgcmag.com We look forward to hearing from you.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.